Physician profile
Christopher C Jernigan
NPI 1811059678
$1,040.49
in general payments reported to CMS, 2019-2025
7 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.15 · 2020: $155 · 2021: $137 · 2022: $60.50 · 2023: $215 · 2024: $110 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580 · Gift: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.23 |
| Gift | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $359.51 | 2024-2025 | Clarity Aligners, Apc Flash-Free Clarity Advanced, Apc II Victory Series |
| 3m Company | $357.24 | 2019-2023 | Clarity Aligners, Apc II Victory Series, Apc II Clarity Advanced |
| Ormco Corporation | $146.64 | 2019-2021 | |
| Align Technology, INC. | $95.10 | 2021 | |
| American Medical & Dental Supplies,INC. | $50.00 | 2019-2025 | |
| World Class Technology Corporation | $26.00 | 2023 | Pitts21, Pitts21 Pro |
| American Orthodontics Corporation | $6.00 | 2024-2025 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jernigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.